THE WHAT? Givaudan said that it will continue to implement price increases in collaboration with its customers to fully compensate for the increase in input costs it is experiencing this year. The flavors and fragrances manufacturer branded its performance in the first three months of the financial year ‘a good start’.
THE DETAILS Sales grew 4.6 percent on a like-for-like basis as compared to the prior year period. Fragrance and Beauty sales hit CHF810 million, up 2.7 percent yoy on a like-for-like basis. Fine Fragrance sales soared 17.4 percent and Active Beauty put on 8.2 percent, while the Consumer Products unit dipped 2.3 percent.
THE WHY? The sales growth was driven by continued strong volume increases in Fine Fragrances with a sustained high level of new business, as well as continued double-digit growth in Active Beauty, Givaudan said. Demand for Fragrance Ingredients continued to remain strong, whilst the performance of Consumer Products was impacted by the strong prior year comparable growth.
Gilles Andrier, CEO, commented, “We are very pleased with the good start that we have made to 2022, despite the challenging external environment affecting many parts of our business. Our good sales growth of 4.6 percent on a like-for-like basis has been achieved against a strong prior year comparable growth of 7.7 percent on a like-for-like basis, and demonstrates the strength of our business and of our organisation in supporting our customers around the world.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
